Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system

70Citations
Citations of this article
59Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

There are several reviews on NO and hydrogen sulfide (H2S) and their role in vascular diseases in the current relevant literature. The aim of this review is to discuss, within the limits of present knowledge, the interconnection between these two gasotransmitters in vascular function. In particular, the review focuses on the role played by the balance between the NO and H2S pathways in either physiological or pathological conditions. The distinction between physiology and pathology has been made in order to dissect the molecular basis of this crosstalk, highlighting how and if this balance varies, depending upon the vascular status. Perspectives and possible novel therapeutic approaches are also discussed. Linked Articles: This article is part of a themed section on Targeting Inflammation to Reduce Cardiovascular Disease Risk. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.22/issuetoc and http://onlinelibrary.wiley.com/doi/10.1111/bcp.v82.4/issuetoc.

Cite

CITATION STYLE

APA

Cirino, G., Vellecco, V., & Bucci, M. (2017, November 1). Nitric oxide and hydrogen sulfide: the gasotransmitter paradigm of the vascular system. British Journal of Pharmacology. John Wiley and Sons Inc. https://doi.org/10.1111/bph.13815

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free